A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy

NCT00106522 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

499

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Methotrexate
DRUG: Placebo
DRUG: tocilizumab [RoActemra/Actemra]
DRUG: tocilizumab [RoActemra/Actemra]

Sponsor

Hoffmann-La Roche